This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Symphogen A/s. Active years: 2011-2012.
Location History:
- Hillroed, DK (2011)
- Hillerød, DK (2012)
Company Filing History:
Years Active: 2011-2012
Title: Anne Bondgaard Tolstrup: Innovator in Recombinant Antibody Technology
Introduction
Anne Bondgaard Tolstrup is a prominent inventor based in Hillerød, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polyclonal antibodies. With a total of 2 patents, her work is paving the way for advancements in therapeutic applications.
Latest Patents
Tolstrup's latest patents include a method for manufacturing an anti-RhD recombinant polyclonal antibody and a method for manufacturing a recombinant polyclonal protein composition. The first patent focuses on a method that involves obtaining a collection of cells transfected with a library of anti-RhD antibody expression vectors. This innovative approach allows for the production of a superior replacement for plasma-derived immunoglobulin products. The second patent outlines a method for creating a recombinant polyclonal protein composition, which is essential for therapeutic uses.
Career Highlights
Anne Bondgaard Tolstrup is currently associated with Symphogen A/S, where she continues to push the boundaries of antibody technology. Her expertise in recombinant proteins has positioned her as a key figure in the biotechnology sector.
Collaborations
Throughout her career, Tolstrup has collaborated with notable colleagues, including Lars Soegaard Nielsen and Dietmar Weilguny. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Anne Bondgaard Tolstrup's innovative work in recombinant antibody technology is making a significant impact in the biotechnology industry. Her patents and collaborations reflect her commitment to advancing therapeutic solutions.